Ben Samelson-Jones, MD, PhDCredit: CHOP Long-Term Safety Profile of Fidanacogene Elaparvovec in Hemophilia B Shows Promise At the recent ASH 2024 conference, Ben Samelson-Jones, MD, PhD, presented exciting long-term safety …
Tag:
Gene Therapy
-
-
Could gene therapy be the revolutionary treatment heart failure patients have been waiting for? A recent study published in npj Regenerative Medicine suggests it’s possible. Researchers from the University of …
Older Posts